IRCT20170123032145N2 IRCT 2018-04-13 Iran University of Medical Sciences L-carnosine in treatment of major depressive disorder L-carnosine as an adjuvant in treatment of major depressive disorder : a randomized double-blind study 2018-04-03 anticipated 50 Complete https://irct.ir/trial/30303 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block Randomization, Blinding description: Investigators who include subjects or evaluate response or side effects are not aware that which group 1/2 is case/control. 2-3 Major Depressive Disorder. Intervention 1: Intervention group: Citalopram tab (max. dose 20mg/day) plus L-carnosine tab 400 mg/ twice per day) for 6 weeks. Intervention 2: Control group: Citalopram tab (max. dose 20mg/day) plus Placebo tab/ twice per day) for 6 weeks. Yes - There is a plan to make this available What will be shared: Data about main outcome of study will be published When: 2020 To whom: Academic researchers Conditions: For scientific goals Where to obtain: shalbafan.mr@iums.ac.ir Dr Mohammadreza Shalbafan How to obtain: Sending an E-mail and reason for request Comments: